Single-cell profiling identifies myeloid cell subsets with distinct fates during neuroinflammation.


Journal

Science (New York, N.Y.)
ISSN: 1095-9203
Titre abrégé: Science
Pays: United States
ID NLM: 0404511

Informations de publication

Date de publication:
25 01 2019
Historique:
received: 02 04 2018
accepted: 14 12 2018
entrez: 26 1 2019
pubmed: 27 1 2019
medline: 1 8 2019
Statut: ppublish

Résumé

The innate immune cell compartment is highly diverse in the healthy central nervous system (CNS), including parenchymal and non-parenchymal macrophages. However, this complexity is increased in inflammatory settings by the recruitment of circulating myeloid cells. It is unclear which disease-specific myeloid subsets exist and what their transcriptional profiles and dynamics during CNS pathology are. Combining deep single-cell transcriptome analysis, fate mapping, in vivo imaging, clonal analysis, and transgenic mouse lines, we comprehensively characterized unappreciated myeloid subsets in several CNS compartments during neuroinflammation. During inflammation, CNS macrophage subsets undergo self-renewal, and random proliferation shifts toward clonal expansion. Last, functional studies demonstrated that endogenous CNS tissue macrophages are redundant for antigen presentation. Our results highlight myeloid cell diversity and provide insights into the brain's innate immune system.

Identifiants

pubmed: 30679343
pii: 363/6425/eaat7554
doi: 10.1126/science.aat7554
pii:
doi:

Substances chimiques

Histocompatibility Antigens Class II 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Subventions

Organisme : European Research Council
Pays : International

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Auteurs

Marta Joana Costa Jordão (MJC)

Institute of Neuropathology, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Faculty of Biology, University of Freiburg, Freiburg, Germany.

Roman Sankowski (R)

Institute of Neuropathology, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Berta-Ottenstein-Programme, Faculty of Medicine, University of Freiburg, Germany.

Stefanie M Brendecke (SM)

Institute of Neuropathology, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Max-Planck-Institute of Immunobiology and Epigenetics, Freiburg, Germany.

Giuseppe Locatelli (G)

Institute of Clinical Neuroimmunology, University Hospital, Ludwig-Maximilians University Munich, Munich, Germany.
Biomedical Center (BMC), Faculty of Medicine, Ludwig-Maximilians University Munich, Munich, Germany.

Yi-Heng Tai (YH)

Institute of Clinical Neuroimmunology, University Hospital, Ludwig-Maximilians University Munich, Munich, Germany.
Biomedical Center (BMC), Faculty of Medicine, Ludwig-Maximilians University Munich, Munich, Germany.

Tuan Leng Tay (TL)

Institute of Neuropathology, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Faculty of Biology, University of Freiburg, Freiburg, Germany.
Cluster of Excellence BrainLinks-BrainTools, University of Freiburg, Freiburg, Germany.

Eva Schramm (E)

Institute of Neuropathology, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Stephan Armbruster (S)

Institute of Neuropathology, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Nora Hagemeyer (N)

Institute of Neuropathology, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Olaf Groß (O)

Institute of Neuropathology, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
BIOSS Centre for Biological Signalling Studies, University of Freiburg, Germany.
Institute of Clinical Chemistry and Pathobiochemistry, University Hospital Rechts der Isar, School of Medicine, Technical University of Munich, Munich, Germany.
CIBSS Centre for Integrative Biological Signalling Studies, University of Freiburg, Germany.

Dominic Mai (D)

Institute of Computer Science, University of Freiburg, Freiburg, Germany.
Life Imaging Center, Center for Biological Systems Analysis, Albert-Ludwigs University, Freiburg, Germany.

Özgün Çiçek (Ö)

Institute of Computer Science, University of Freiburg, Freiburg, Germany.

Thorsten Falk (T)

BIOSS Centre for Biological Signalling Studies, University of Freiburg, Germany.
Institute of Computer Science, University of Freiburg, Freiburg, Germany.

Martin Kerschensteiner (M)

Institute of Clinical Neuroimmunology, University Hospital, Ludwig-Maximilians University Munich, Munich, Germany.
Biomedical Center (BMC), Faculty of Medicine, Ludwig-Maximilians University Munich, Munich, Germany.
Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.

Dominic Grün (D)

Max-Planck-Institute of Immunobiology and Epigenetics, Freiburg, Germany.

Marco Prinz (M)

Institute of Neuropathology, Faculty of Medicine, University of Freiburg, Freiburg, Germany. marco.prinz@uniklinik-freiburg.de.
BIOSS Centre for Biological Signalling Studies, University of Freiburg, Germany.
CIBSS Centre for Integrative Biological Signalling Studies, University of Freiburg, Germany.
Centre for NeuroModulation, University of Freiburg, Germany.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
C-Reactive Protein Humans Biomarkers Inflammation
Humans Immune Checkpoint Inhibitors Lung Neoplasms Prognosis Inflammation

Classifications MeSH